Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Chronic kidney disease (CKD) represents an increasing global public health problem due to its high prevalence and its significant impact on patients’ quality of life and healthcare systems. Progression to end-stage disease often requires renal replacement therapy (RRT), posing a major clinical and epidemiological challenge. Identifying the underlying etiology and associated comorbidities is essential for developing prevention, early diagnosis, and treatment strategies. However, there are no epidemiological reports characterizing this population in the state of Nayarit, Mexico.
To describe the etiology of end-stage chronic kidney disease in patients undergoing renal replacement therapy in the state of Nayarit. All patients diagnosed with end-stage chronic kidney disease who received renal replacement therapy between May 2023 and July 2025 at “Dr. Aquiles Calles Ramírez” General Hospital (ISSSTE) were included.
A total of 248 patients were included. Their main characteristics are summarized in Table 1. The leading cause of end-stage CKD among patients receiving RRT was diabetes mellitus (47%), followed by undetermined etiology (24%), arterial hypertension (11%), obstructive nephropathy (8%), glomerulonephritis (8%), and polycystic kidney disease (2%).
Chronic kidney disease is influenced by multiple factors, including geographic and sociocultural conditions. Understanding the etiology of end-stage CKD in each region is essential. In our study, diabetic nephropathy was the most common cause, consistent with other reports in Mexico. However, a high proportion of cases with undetermined etiology was observed, highlighting the need to improve diagnostic approaches and epidemiological registry systems in the region.
